Many tumors express the protein PD-L1, which allows them to circumvent the immune system. Scientists at Israel’s Technion Institute have developed neural networks that use “deep learning” AI to recognize PD-L1 in biopsies, alerting oncologists to apply appropriate immunotherapy.

https://www.technion.ac.il/en/2022/11/deep-learning-breast-cancer-ai-immunotherapy/